Sine Keith, Vaillancourt Régis, Pascuet Elena, Martelli Brenda, Lamontagne Christine, Ellis Jacqueline, Wong Elaine, Gaboury Isabelle
, BSc(Pharm), PharmD, is with the Department of Pharmacy, Children's Hospital of Eastern Ontario, Ottawa, Ontario. At the time of the study, he was a PharmD student with the University of Toronto.
Can J Hosp Pharm. 2011 Jan;64(1):25-30. doi: 10.4212/cjhp.v64i1.983.
Several changes to medication safety practices were proposed in a pediatric hospital, including changing the period of patient observation after administration of opioids and limiting the availability of various concentrations of morphine in the patient care unit.
To document and review postoperative pain management for children on a surgical ward, specifically with regard to intermittent IV bolus administration of morphine, to help in assessing the impact of the proposed nursing practice changes.
Data were collected from records for narcotics and controlled drugs for the surgical ward over a 3-month period (April to June 2006). For each patient, data had been recorded for up to 7 consecutive days after surgery. A patient's data were included in the review if he or she had received at least 2 doses of morphine by IV bolus, except for the review of weight-based dosing pattern (mg/kg), for which all patients who had received at least one dose of IV morphine were included.
Charts for 193 patients were audited. Of these, 163 patients (84.5%) had recieved up to 0.1 mg/kg per dose, and 53 (27.5%) had received only one dose of morphine. Among patients who received more than one dose, the median dose was 0.080 mg/kg on day 1, with a decrease by day 5 to 0.065 mg/kg. Most patients received morphine over the first 2 days after surgery. The median time elapsed between doses was 4.3 h on day 1 and 6.2 h on day 2. Of the 1020 doses included in the analysis, most (801 [78.5%]) were 4 mg or less.
The intermittent administration of IV bolus doses of morphine at the study hospital followed common standards for the treatment of postoperative pain. Most doses were no more than 4 mg. On the basis of this information, only 2-mg vials of morphine are now stocked on the ward. The hospital's change in monitoring practices will increase the surveillance of patients receiving IV bolus doses of morphine.
一家儿科医院提出了多项药物安全措施的改变,包括改变阿片类药物给药后患者的观察期,以及限制患者护理单元中不同浓度吗啡的可及性。
记录并审查外科病房儿童术后疼痛管理情况,特别是关于静脉注射吗啡的间歇性推注给药,以帮助评估拟议的护理实践改变的影响。
收集了外科病房3个月期间(2006年4月至6月)的麻醉药品和管制药品记录数据。对于每位患者,术后连续记录长达7天的数据。如果患者至少接受过2次静脉推注吗啡,则其数据纳入审查,但基于体重的给药模式(mg/kg)审查中,纳入所有至少接受过1次静脉注射吗啡的患者。
审核了193例患者的病历。其中,163例患者(84.5%)每剂接受剂量高达0.1mg/kg,53例(27.5%)仅接受过1剂吗啡。在接受多剂吗啡的患者中,第1天的中位剂量为0.080mg/kg,到第5天降至0.065mg/kg。大多数患者在术后头2天接受吗啡治疗。第1天剂量间隔的中位时间为4.3小时,第2天为6.2小时。在分析的1020剂吗啡中,大多数(801剂[78.5%])为4mg或更低剂量。
研究医院静脉推注吗啡的间歇性给药遵循术后疼痛治疗的通用标准。大多数剂量不超过4mg。基于这些信息,病房现仅储备2mg装的吗啡小瓶。医院监测实践的改变将加强对接受静脉推注吗啡患者的监测。